Azithromycin Shows No Benefits in Preventing or Treating COVID-19 in Hospitalized Patients

Two recent studies have just been published in the scientific literature reporting on the lack of benefits and the occurrence of side effects when taking azithromycin to treat or prevent Covid-19.

Azithromycin For Coronavirus

Azithromycin For Coronavirus

Azithromycin is an antibiotic that belongs to the macrolide family that works by inhibiting protein synthesis in bacteria and spread particularly in our cells. Against Covid-19, this molecule has had its moment of glory, as it is the antibiotic used in the protocol proposed by Didier Raoult of Marseille France. However, recently published studies show that it is not effective in preventing mortality and has notable side effects.

Read Also: Like Remdesivir Chloroquine and Azithromycin Also Shorten Hospital Stays by More Than 30% According to Senegalese Study

Azithromycin has no effect on rates of mortality

According to data from the UK Recovery Study, the prescription of azithromycin against Covid-19 makes no difference in mortality at 28 days compared to placebo. Similarly, it did not reduce the incidence of cases requiring mechanical ventilation. The results of this study are consistent across all study subgroups.

Serious side effects

Read Also: 3 French Doctors Are Using Azithromycin With Zinc to Save Lives

The prescription of antibiotics is not without consequences, both at the individual and population level. In fact, in a recent study published in the New England Journal of Medicine, the massive prescription of macrolides has led to an increase in antibiotic resistance to these therapies in regions where this drug was massively prescribed compared to regions receiving placebos. In addition, a retrospective study published in Clinical Microbiology Infection suggests that the overprescription of azithromycin is associated with increased pulmonary aspergillosis a type of pneumonia caused by a fungal infection. This side effect of the drug was already known and has now been seen in Covid-19 patients that were prescribed the antibiotic.

Read Also: COVID-19: Remdesivir, Lopinavir, Interferon Beta-1A and Hydroxychloroquine Not Effective WHO Study Shows


RECOVERY trial finds no benefit from azithromycin in patients hospitalized with COVID-19

Recommended Reads:

Health News

Coronavirus Pandemic: The Flip-Flops of the Scientific Community

Is There A Link Between Pandemics and Climate Change?

Vaccines May Protect You Against Other Diseases Besides Those They Were Made for According To Study

Too Much Salt Weakens the Immune System According to Study

Genf20 Plus Review: Why Are People Rushing to Buy This HGH Supplement?

COVID-19: All the Essential Vitamins and Minerals for a Strong Immune System

Growth Factor Plus: Benefits, Ingredients, Side effects, Cost and Testimonials

Immune Defence Review: Swiss Research Labs Develops Lozenges to Boost Immune Response



Want to Stay Informed?

Join the Gilmore Health News Newsletter!